ICU置管时同期使用全身抗生素与导管相关感染:五项大型随机对照试验个体数据事后分析
多变量Cox和倾向评分模型显示,抗生素组与非抗生素组的重大导管相关感染(HR 0.83,95%CI 0.62-1.10,p 0.19)和导管相关血流感染(HR 0.85,95%CI 0.60-1.22,p 0.38)风险相似。结论认为置管时正在使用抗生素与导管相关感染风险降低无关,不应为预防此类感染而使用。
要点
- 置管时正在使用抗生素未降低重大导管相关感染和导管相关血流感染风险。
- 未发现特定抗生素亚类可降低重大导管相关感染风险。
- 抗生素组非发酵革兰阴性杆菌检出更频繁,提示经验性用药需考虑菌群影响。
核心结论
- 置管时正在使用抗生素与导管相关感染风险降低无关,不应为预防此类感染而使用。
- 结果对重症患者抗菌药物管理有启示,并可能指导疑似血管内导管感染时的经验性抗菌治疗。
研究设计与样本
- 分析对象为ICU内需置入动脉导管、短期中心静脉导管或透析导管的成人患者。
- 采用多变量边际Cox模型和倾向评分模型估计置管时抗生素使用对感染结局的影响。
主要发现
- 校正已知血管内导管感染危险因素后,重大导管相关感染风险相似(HR 0.83,95%CI 0.62-1.10,p 0.19)。
- 导管相关血流感染风险相似(HR 0.85,95%CI 0.60-1.22,p 0.38)。
- 倾向评分验证分析结果一致,未发现特定抗生素亚类降低重大导管相关感染风险。
- 非发酵革兰阴性杆菌在抗生素组更常见。
临床怎么用
- 不应仅因预防导管相关感染而在置管时使用全身抗生素。
- 疑似血管内导管感染时,经验性抗菌治疗需结合本研究提示的菌群分布特点。
- 重症患者抗菌药物管理应关注置管时非必要的抗生素使用。
局限性
- 为事后分析,非预设主要终点,存在残余混杂可能。
- 抗生素暴露定义为置管时正在使用,未区分用药指征和疗程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data on the impact of systemic antibiotics at the time of catheter insertion are scarce. Therefore, we assessed the association between concurrent antibiotic administration at insertion and short-term catheter-related infections. METHODS: We used individual data gathered from five large, randomized, controlled ICU trials. We analysed adult patients who required arterial, short-term central venous or dialysis catheter insertion in the ICU. The effect of antibiotics at insertion on major catheter-related infection (MCRI), catheter-related bloodstream infection (CRBSI) and colonization was estimated using multivariate marginal Cox and propensity score models. RESULTS: We included 10 269 patients and 18 743 catheters from 36 ICUs. Antibiotic use was ongoing at the time of 11 361 catheter insertions (60.6%). After adjusting for well-known risk factors for intravascular catheter infection, we observed a similar risk for MCRI (HR 0.83, 95%CI 0.62-1.10, p 0.19) and CRBSI (HR 0.85, 95%CI 0.60-1.22, p 0.38) between the antibiotic and no-antibiotic groups. A confirmatory analysis using propensity score showed consistent results. No specific antibiotic subclasses reduced the risk of MCRI. Non-fermenting Gram-negative bacilli were more frequently observed in the antibiotic group. CONCLUSIONS: Ongoing antibiotic administration at the time of catheter insertion was not associated with a decrease risk of catheter-related infections and should not be carried out for preventing such infections. Our results bring new insights to antimicrobial stewardship in critically ill patients and may direct empirical antimicrobial therapy if an intravascular catheter infection is suspected.
引用
- Buetti N, Souweine B, Mermel L, et al. Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs. Clin Microbiol Infect. 2020. PMID: 33152538. doi:10.1016/j.cmi.2020.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。